No Data
No Data
Terns Pharmaceuticals(TERN.US) Director Buys US$5 Million in Common Stock
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc
With 55% Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Boasts of Strong Institutional Backing
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Raises Target Price to $26
Express News | Terns Pharmaceuticals Inc : BMO Raises Target Price to $26 From $19
Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Aura Biosciences Inc (AURA) and Terns Pharmaceuticals (TERN)